DePrince Race & Zollo Inc (DRZ)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-506,054
| Closed | -$29.4M | – | 180 |
|
|
2023
Q3 | $29.4M | Buy |
506,054
+41,361
| +9% | +$2.4M | 0.71% | 52 |
|
|
2023
Q2 | $29.7M | Buy |
464,693
+104,879
| +29% | +$6.71M | 0.68% | 53 |
|
|
2023
Q1 | $24.9M | Sell |
359,814
-5,081
| -1% | -$352K | 0.58% | 77 |
|
|
2022
Q4 | $26.3M | Sell |
364,895
-40,447
| -10% | -$2.91M | 0.6% | 82 |
|
|
2022
Q3 | $28.8M | Buy |
405,342
+1,903
| +0.5% | +$135K | 0.74% | 57 |
|
|
2022
Q2 | $31.1M | Sell |
403,439
-112,507
| -22% | -$8.66M | 0.72% | 62 |
|
|
2022
Q1 | $37.7M | Sell |
515,946
-75,386
| -13% | -$5.51M | 0.73% | 55 |
|
|
2021
Q4 | $36.9M | Buy |
591,332
+118,081
| +25% | +$7.36M | 0.94% | 28 |
|
|
2021
Q3 | $28M | Sell |
473,251
-8,475
| -2% | -$501K | 0.75% | 49 |
|
|
2021
Q2 | $32.2M | Buy |
481,726
+11,827
| +3% | +$790K | 0.81% | 29 |
|
|
2021
Q1 | $29.7M | Buy |
469,899
+86,204
| +22% | +$5.44M | 0.8% | 33 |
|
|
2020
Q4 | $23.8M | Buy |
383,695
+54,657
| +17% | +$3.39M | 0.75% | 38 |
|
|
2020
Q3 | $19.8M | Buy |
329,038
+64,453
| +24% | +$3.89M | 0.74% | 42 |
|
|
2020
Q2 | $15.6M | Sell |
264,585
-53,168
| -17% | -$3.13M | 0.6% | 67 |
|
|
2020
Q1 | $17.7M | Sell |
317,753
-62,545
| -16% | -$3.49M | 0.81% | 39 |
|
|
2019
Q4 | $24.4M | Sell |
380,298
-144,544
| -28% | -$9.28M | 0.74% | 45 |
|
|
2019
Q3 | $26.6M | Buy |
524,842
+47,721
| +10% | +$2.42M | 0.77% | 43 |
|
|
2019
Q2 | $21.6M | Buy |
477,121
+56,756
| +14% | +$2.57M | 0.6% | 70 |
|
|
2019
Q1 | $20.1M | Buy |
+420,365
| New | +$20.1M | 0.55% | 82 |
|